Filing Details
- Accession Number:
- 0001209191-14-048767
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-23 21:54:18
- Reporting Period:
- 2014-07-21
- Filing Date:
- 2014-07-23
- Accepted Time:
- 2014-07-23 21:54:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Biotime Inc | BTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202529 | D Michael West | 1301 Harbor Bay Parkway Alameda CA 94502 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Acquisiton | 2014-07-21 | 1,470,400 | $0.50 | 1,580,000 | No | 4 | M | Direct | |
| Common Shares, No Par Value | Disposition | 2014-07-21 | 434,013 | $2.65 | 1,145,987 | No | 4 | F | Direct | |
| Common Shares, No Par Value | Disposition | 2014-07-22 | 270,000 | $2.65 | 875,987 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option to Purchase Common Shares | Disposition | 2014-07-21 | 1,470,400 | $0.00 | 1,470,400 | $0.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-10-09 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Option to Purchase Common Shares | $4.22 | 2020-02-19 | 200,000 | 200,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $3.51 | 2021-03-19 | 200,000 | 200,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-02-19 | 200,000 | 200,000 | Direct |
| 2021-03-19 | 200,000 | 200,000 | Direct |
Footnotes
- Does not include shares that may be acquired upon the exercise of certain stock options.
- These shares were surrendered to the company for two purposes: 1) as consideration for the exercise of options on July 21, 2014, and 2) as consideration to satisfy a portion of the income tax liability arising from the exercise of options on July 21, 2014. The options exercised were due to expire on October 9, 2014.
- These shares were sold in a privately negotiated transaction to a single purchaser to obtain funds to pay additional taxes arising from the exercise of options on July 21, 2014.
- 1/60th of the number of options became exercisable at the end of each full month of employment after October 10, 2007.
- 1/48th of the number of options will vest and become exercisable at the end of each full month of employment after January 1, 2013.
- 1/48th of the number of options will vest and become exercisable at the end of each full month of employment after March 20, 2014.
Billionaire Hedge Funds
